Brief report: T cell expression of granulocyte-macrophage colony-stimulating factor in juvenile arthritis is contingent upon th17 plasticity

Arthritis and Rheumatology

Volumn 66, Issue 7, 2014, Pages 1955-1960

  Piper, Christopher ^a   Pesenacker, Anne M ^a   Bending, David ^a   Thirugnanabalan, Balathas ^a   Varsani, Hemlata ^a   Wedderburn, Lucy R ^a   Nistala, Kiran ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SYNOVIAL FLUID; T LYMPHOCYTE; TH17 CELL; UPREGULATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM;

ARTHRITIS, JUVENILE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNITY, INNATE; MALE; SYNOVIAL FLUID; TH17 CELLS;

EID: 84903465287     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38647     Document Type: Article

References (19)

1. Nistala K, Woo P, Wedderburn LR,. Juvenile idiopathic arthritis. In:, Firestein GS, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent JS, editors. Kelley's textbook of rheumatology. 8th ed. Oxford: Elsevier; 2009. p. 1657-76.
2. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, et al, for the Pediatric Rheumatology Collaborative Study Group. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003; 48: 218-26.
3. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-7.
4. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR,. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58: 875-87.
5. Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 2504-15.
6. Codarri L, Gyulveszi G, Tosevski V, Hesske L, Fontana A, Magnenat L, et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol 2011; 12: 560-7.
7. H17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol 2011; 12: 568-75.
8. Gattorno M, Facchetti P, Ghiotto F, Vignola S, Buoncompagni A, Prigione I, et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0-type pattern of cytokine secretion irrespective of immunophenotype. Clin Exp Immunol 1997; 109: 4-11.
9. Cornish AL, Campbell IK, McKenzie BS, Chatfield S, Wicks IP,. G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis. Nat Rev Rheumatol 2009; 5: 554-9.
10. Cook AD, Turner AL, Braine EL, Pobjoy J, Lenzo JC, Hamilton JA,. Regulation of systemic and local myeloid cell subpopulations by bone marrow cell-derived granulocyte-macrophage colony-stimulating factor in experimental inflammatory arthritis. Arthritis Rheum 2011; 63: 2340-51.
11. Campbell IK, van Nieuwenhuijze A, Segura E, O'Donnell K, Coghill E, Hommel M, et al. Differentiation of inflammatory dendritic cells is mediated by NF-κB1-dependent GM-CSF production in CD4 T cells. J Immunol 2011; 186: 5468-77.
12. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115: 335-43.
13. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
14. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
15. + T cell precursor. J Exp Med 2008; 205: 1903-16.
16. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 2011; 12: 255-63.
17. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-61.
18. Cannon GW, Pincus SH, Emkey RD, Denes A, Cohen SA, Wolfe F, et al. Double-blind trial of recombinant γ-interferon versus placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1989; 32: 964-73.
19. Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, et al, for the EARTH Study Group. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis 2013; 72: 1445-52.